These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 19949936)
1. Overcoming multidrug resistance by RNA interference. Stege A; Krühn A; Lage H Methods Mol Biol; 2010; 596():447-65. PubMed ID: 19949936 [TBL] [Abstract][Full Text] [Related]
2. Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference. Stege A; Priebsch A; Nieth C; Lage H Cancer Gene Ther; 2004 Nov; 11(11):699-706. PubMed ID: 15375376 [TBL] [Abstract][Full Text] [Related]
3. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors. Gan HZ; Zhang GZ; Zhao JS; Zhang FC; Bu LS; Yang SJ; Piao SL; Du ZW; Gao S; Zheng DM Chin Med J (Engl); 2005 Jun; 118(11):893-902. PubMed ID: 15978189 [TBL] [Abstract][Full Text] [Related]
4. Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes. Kaszubiak A; Holm PS; Lage H Int J Oncol; 2007 Aug; 31(2):419-30. PubMed ID: 17611700 [TBL] [Abstract][Full Text] [Related]
5. Regulation of MDR1 gene expression in multidrug-resistant cancer cells is independent from YB-1. Kaszubiak A; Kupstat A; Müller U; Hausmann R; Holm PS; Lage H Biochem Biophys Res Commun; 2007 May; 357(1):295-301. PubMed ID: 17418094 [TBL] [Abstract][Full Text] [Related]
6. MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance. Lage H Curr Drug Targets; 2006 Jul; 7(7):813-21. PubMed ID: 16842213 [TBL] [Abstract][Full Text] [Related]
7. In vivo reversal of P-glycoprotein-mediated multidrug resistance by efficient delivery of stealth RNAi. Xiao H; Wu Z; Shen H; Luo AL; Yang YF; Li XB; Zhu DY Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):342-8. PubMed ID: 18834355 [TBL] [Abstract][Full Text] [Related]
8. The reversion effect of the RNAi-silencing mdr1 gene on multidrug resistance of the leukemia cell HT9. Shao SL; Sun YY; Li XY; Zhang WW; Fu B; Yun DZ; Zuo MX Cell Biol Int; 2008 Aug; 32(8):893-8. PubMed ID: 18499486 [TBL] [Abstract][Full Text] [Related]
9. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1. Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441 [TBL] [Abstract][Full Text] [Related]
10. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells. Zhang T; Guan M; Jin HY; Lu Y Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151 [TBL] [Abstract][Full Text] [Related]
11. Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1. Yagüe E; Higgins CF; Raguz S Gene Ther; 2004 Jul; 11(14):1170-4. PubMed ID: 15164094 [TBL] [Abstract][Full Text] [Related]
12. Recent attempts at RNAi-mediated P-glycoprotein downregulation for reversal of multidrug resistance in cancer. Abbasi M; Lavasanifar A; Uludag H Med Res Rev; 2013 Jan; 33(1):33-53. PubMed ID: 21523793 [TBL] [Abstract][Full Text] [Related]
13. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1. Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188 [TBL] [Abstract][Full Text] [Related]
14. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells. Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341 [TBL] [Abstract][Full Text] [Related]
15. Reversal of MDR1 gene-dependent multidrug resistance using low concentration of endonuclease-prepared small interference RNA. Li L; Xu J; Min T; Huang W Eur J Pharmacol; 2006 Apr; 536(1-2):93-7. PubMed ID: 16564522 [TBL] [Abstract][Full Text] [Related]
16. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells. Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039 [TBL] [Abstract][Full Text] [Related]
17. Selection of antisense oligonucleotides for reversal of multidrug resistance in breast carcinoma cells. Gao P; Zhou GY; Lei DP; Zhang XF; Li L; Xu JW; Lin XY Cytotherapy; 2007; 9(8):795-801. PubMed ID: 17917879 [TBL] [Abstract][Full Text] [Related]
18. Modulating multidrug resistance gene in leukaemia cells by short interfering RNA. Lim MN; Lau NS; Chang KM; Leong CF; Zakaria Z Singapore Med J; 2007 Oct; 48(10):932-8. PubMed ID: 17909680 [TBL] [Abstract][Full Text] [Related]
19. Reverse multidrug resistance in laryngeal cancer cells by knockdown MDR1 gene expression. Zhigang H; Qi Z; Jugao F; Xiaohong C; Wei Z; Hong W; Hu H; Na M; Zheng Y; Demin H J Otolaryngol Head Neck Surg; 2009 Aug; 38(4):440-8. PubMed ID: 19755084 [TBL] [Abstract][Full Text] [Related]
20. Jet-injection of short hairpin RNA-encoding vectors into tumor cells. Walther W; Stein U; Lage H Methods Mol Biol; 2010; 629():123-39. PubMed ID: 20387147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]